Fundraising FoxBiotech Startups
11,124 companies tagged Biotech, with their investors and founders.
Polybiomics develops a live cell analysis platform that measures multiple phenotypes and functions of cells simultaneously and continuously without disrupting them or their 3D environments. The system combines a bioinstrument, consumable, and the PolyData analytics engine with AI to interpret multimodal datasets for research, pharmaceutical, biomanufacturing, and clinical workflows.
0 investors
0 investors
0 investors
PolyVascular develops a polymer-based transcatheter pulmonary heart valve for pediatric patients with congenital heart conditions. The medical device company focuses on providing durable, minimally invasive valve replacements for children.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Praeventix is an early-stage biopharmaceutical company developing serotonergic (5-HT7 receptor) therapeutics, with a lead topical candidate PRA-523 aimed at treating chronic pruritus in conditions such as atopic dermatitis. It is also researching 5-HT7 modulators for inflammatory bowel disease and cocaine use disorder.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Precision Biologics develops therapeutic and diagnostic products for cancer patients. The company operates in the oncology biotech space in the United States.
0 investors
Precision Epigenomics develops EPISEEK, a blood-based multi-cancer early detection test that analyzes hypermethylated DNA loci to identify DNA changes linked to over 60 cancer types before symptoms appear. The test serves higher-risk individuals, health-conscious people aged 45+, healthcare providers, and wellness programs, with lab analysis performed at a CAP-accredited, CLIA-certified lab.
0 investors
Neuropharmagen provides genetic testing and analysis to help healthcare providers identify the most effective psychotropic medications and dosages for patients with mental health conditions such as depression, anxiety, and bipolar disorder.
0 investors
0 investors
0 investors
0 investors
0 investors